
|Articles|November 15, 2002
Feds Warn Drugmakers About Marketing Tactics
Dermatologists should be aware of new warnings from the federal government to drug manufacturers, cautioning against marketing practices that could be in violation of federal anti-kickback laws.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Medicus Pharma Completes Phase 2 Enrollment of D-MNA Study to Non-Invasively Treat BCC
3
Phase 2 Nemolizumab Trial Opens for CPUO
4
Transformative Advances This Year and Beyond
5


















